Zacks Research Issues Positive Outlook for LLY Earnings
Eli Lilly and Company ( NYSE:LLY – Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The ...
pharmaphorum1d
Lilly slashes insulin price 70%, patient cost cap now $35
On which point, Lilly is also cutting the list price of Humalog 100 units/mL – its most commonly prescribed insulin – and Humulin (insulin human) injection 100 units/mL, by 70%, effective as ...
pharmaphorum7d
Why the drug pricing debate is focused on insulin
Later, synthetic ‘human’ insulin was developed in 1978 and then commercialised by Eli Lilly in 1982 as Humulin. In recent years, there have been more developments in the area of diabetes ...
Medscape1d
Room-temperature Storage of Medications Labeled for Refrigeration
28 days Prescribing information Lente human insulin (rDNA origin) zinc suspension Humulin L (Lilly) 28 days Prescribing information Insulin lispro (rDNA origin) vial Humalog vial (Lilly ...
BioSpace26d
Sanofi Challenges Novo With First FDA Nod for NovoLog Biosimilar
Lilly had announced steep price cuts at the time, planning a 70% reduction in cost for Humalog and Humulin—both short-acting insulin products—and capping patients’ out-of-pocket at $35 per month. The ...